Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly t(15;17)(q24;q21). (A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of acute promyelocytic leukemia.)
No clinical trials have been registered for acute myeloid leukemia, t(15;17)(q24;q21).
3 publications have been identified in PubMed for acute myeloid leukemia, t(15;17)(q24;q21). Research spans Case Report / Case Series (100%).
Chen JP (2026). [PMID: 42057828](https://pubmed.ncbi.nlm.nih.gov/42057828/). *Front Oncol*. [Case Report / Case Series]
Kachhwaha A (2025). [PMID: 40873181](https://pubmed.ncbi.nlm.nih.gov/40873181/). *Cardiovasc Hematol Disord Drug Targets*. [Case Report / Case Series]
Frazzetto S (2024). [PMID: 38921185](https://pubmed.ncbi.nlm.nih.gov/38921185/). *Hematol Rep*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
Common questions about acute myeloid leukemia, t(15;17)(q24;q21)